Vicore Pharma Holding AB (VCRE) Price Prediction & ForecastVCREVicore Pharma Holding AB

Alphio's VCRE stock price prediction model matches the current Vicore Pharma Holding AB tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $9.27 (-1.81%). The 1-week path is $9.46 (+0.20%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Vicore Pharma (VCRE) is a good buy right now due to its favorable technical indicators and positive analyst outlook. The current price is $9.59, significantly below the analyst price target of $25, indicating a potential upside of over 160%. Additionally, the stock has shown a recent 5-day change of +2.02%, suggesting a positive momentum. However, the main risk is the negative net income trend, with a net income loss of -142,844,000 SEK in Q2 2026, which highlights ongoing financial challenges.

Vicore Pharma Holding AB (VCRE) last closed at $9.4399996, gaining +3.06%. These facts feed the 1-day and 1-week VCRE price prediction above.